Novel Diuretic Strategies for the Treatment of Heart Failure in Japan

被引:26
作者
Dohi, Kaoru [1 ]
Ito, Masaaki [1 ]
机构
[1] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan
关键词
Diuretics; Heart failure; Japanese; WORSENING RENAL-FUNCTION; ATRIAL-NATRIURETIC-PEPTIDE; NATIONAL REGISTRY ADHERE; CHRONIC KIDNEY-DISEASE; LOOP DIURETICS; ORAL TOLVAPTAN; DOUBLE-BLIND; VASOPRESSIN ANTAGONIST; HOSPITALIZED-PATIENTS; SYSTOLIC DYSFUNCTION;
D O I
10.1253/circj.CJ-14-0592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluid management is of paramount importance in the treatment strategy of heart failure (HF), but the therapeutic efficacy of loop diuretic-based treatment for HF patients is limited by insufficient response and adverse effects. Clinical data establishing the efficacy and safety of tolvaptan, a selective oral vasopressin V2 receptor antagonist that induces aquaresis, have recently been accumulated over 3 years of daily clinical experience in Japan. Intravenous infusion of carperitide, a synthetic a-human atrial natriuretic peptide, has also been widely used as acute-phase therapy for acute decompensated HF in Japan. Combination therapy using loop diuretics, tolvaptan, and carperitide with differing and complementary mechanisms of action may maximize therapeutic activity, to minimize the dosage of loop diuretics and thereby reduce the adverse effects not only for volume removal but also for the stability of cardiorenal hemodynamics.
引用
收藏
页码:1816 / 1823
页数:8
相关论文
共 67 条
[1]   Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization [J].
Abdel-Qadir, Husam M. ;
Tu, Jack V. ;
Yun, Lingsong ;
Austin, Peter C. ;
Newton, Gary E. ;
Lee, Douglas S. .
AMERICAN HEART JOURNAL, 2010, 160 (02) :264-U80
[2]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[3]   Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods [J].
Ahmed, Ali ;
Husain, Ahsan ;
Love, Thomas E. ;
Gambassi, Giovanni ;
Dell'Italia, Louis J. ;
Francis, Gary S. ;
Gheorghiade, Mihai ;
Allman, Richard M. ;
Meleth, Sreelatha ;
Bourge, Robert C. .
EUROPEAN HEART JOURNAL, 2006, 27 (12) :1431-1439
[4]   Sodium Retention in Heart Failure and Cirrhosis Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist? [J].
Bansal, Shweta ;
Lindenfeld, JoAnn ;
Schrier, Robert W. .
CIRCULATION-HEART FAILURE, 2009, 2 (04) :370-376
[5]   ACUTE HEMODYNAMIC AND NEUROENDOCRINE EFFECTS OF DOPEXAMINE, A NEW VASODILATOR FOR THE TREATMENT OF HEART-FAILURE - COMPARISON WITH DOBUTAMINE, CAPTOPRIL, AND NITRATE [J].
BAYLISS, J ;
THOMAS, L ;
POOLEWILSON, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (05) :551-554
[6]   Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia [J].
Berl, Tomas ;
Quittnat-Pelletier, Friederike ;
Verbalis, Joseph G. ;
Schrier, Robert W. ;
Bichet, Daniel G. ;
Ouyang, John ;
Czerwiec, Frank S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (04) :705-712
[7]   Relationship between heart failure treatment and development of worsening renal function among hospitalized patients [J].
Butler, J ;
Forman, DE ;
Abraham, WT ;
Gottlieb, SS ;
Loh, E ;
Massie, BM ;
O'Connor, CM ;
Rich, MW ;
Stevenson, LW ;
Wang, YF ;
Young, JB ;
Krumholz, HM .
AMERICAN HEART JOURNAL, 2004, 147 (02) :331-338
[8]   Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure [J].
Costanzo, Maria Rosa ;
Guglin, Maya E. ;
Saltzberg, Mitchell T. ;
Jessup, Mariell L. ;
Bart, Bradley A. ;
Teerlink, John R. ;
Jaski, Brian E. ;
Fang, James C. ;
Feller, Erika D. ;
Haas, Garrie J. ;
Anderson, Allen S. ;
Schollmeyer, Michael P. ;
Sobotka, Paul A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) :675-683
[9]   Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure [J].
Costello-Boerrigter, LC ;
Smith, WB ;
Boerrigter, G ;
Ouyang, J ;
Zimmer, CA ;
Orlandi, C ;
Burnett, JC .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (02) :F273-F278
[10]   Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) [J].
Cowie, MR ;
Komajda, M ;
Murray-Thomas, T ;
Underwood, J ;
Ticho, B .
EUROPEAN HEART JOURNAL, 2006, 27 (10) :1216-1222